Does trastuzumab increase ONJ development due to zoledronic acid treatment in breast cancer?

Author
Sarsenov, D.
Pilanci, K. N.
Alco, G.
Ordu, C.
Celebi, F.
Ozmen, V.
Ilgun, S.
Agacayak, F.
Iyigun, Z. Erdogan
Metadata
Show full item record
URI
http://hdl.handle.net/20.500.12627/24454
https://doi.org/10.1016/s0960-9776(15)70157-8
Collections